MedPath

Evaluation of a newly developed scoring system for detection of early pancreatic cancer: A prospective multi center study.

Not Applicable
Conditions
Pancreatic cancer
Registration Number
JPRN-UMIN000033092
Lead Sponsor
ew Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
3500
Inclusion Criteria

Not provided

Exclusion Criteria

Cases in which pancreatic cancer is strongly suspected by other image modality before screening. Cases in which pancreatic screening had been already performed and followed. When informed consent can not be obtained.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection of pancreatic cancer and early pancreatic cancer less than 10 mm in diameter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath